Harbor Light Capital Partners

Harbor Light Capital Partners, established in 2008 and headquartered in Keene, New Hampshire, is a private equity firm specializing in early-stage investments. It focuses on innovative and disruptive technology, healthcare, and other select sectors, primarily in New England and the Intermountain West. The firm invests in the $1-$5 million range, offering flexibility beyond traditional holding periods to support the long-term growth of family-owned and emerging growth businesses. Harbor Light provides active board and operational engagement, leveraging its expertise and networks to drive value and facilitate expansion. It seeks companies with strong intellectual property, large market potential, and exceptional management teams, preferring those with recurring revenue streams and a focus on customer intimacy.

Gordon Finnegan

Principal

Darby Kopp

General Partner

Todd Warden

Co-Founder and Managing Partner

16 past transactions

Carmell Cosmetics

Series B in 2017
Carmell was founded in 2007 to commercialize technology developed jointly at Carnegie Mellon University and Allegheny General Hospital. The proprietary technology enables the manufacture of biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. These plastics are sterile, off-the-shelf, easy to handle, shape and suture, have controlled degradation rates, contain known levels of bioactivity, and exhibit mechanical properties designed to match the repaired tissue. Carmell's plastics can be simply viewed as plastic forms of ultra-concentrated blood clots; they therefore represent the ideal biomaterials, using the body's own growth and regenerative factors to naturally promote tissue healing. The Company is focused on the sports medicine market, with products designed to accelerate healing and produce better clinical outcomes in treating injuries to connective tissue (e.g., tendons, ligaments and cartilage).

Courtagen Life Sciences

Private Equity Round in 2015
Courtagen Life Sciences, Inc. is a biotechnology company based in Woburn, Massachusetts, specializing in genetic testing services. The company provides a range of clinical genetic tests focused on neurological conditions, including developmental delay, intellectual disability, autism spectrum disorders, epilepsy, and mitochondrial disorders. Its offerings include comprehensive analyses such as epiSEEK Comprehensive and epiSEEK Focus, which assess genes associated with neurological function and seizure disorders, respectively. Additionally, Courtagen offers tests for drug metabolism related to epilepsy, as well as panels for neurodevelopmental and lysosomal storage disorders. The company also provides next generation sequencing services to support research in target discovery, clinical development, and companion diagnostics. Founded in 2003, Courtagen Life Sciences aims to empower physicians, families, and children affected by neurological disorders through advanced genetic insights.

Senet

Series A in 2015
Senet, Inc. specializes in providing Internet of Things (IoT) connectivity solutions through a scalable low power wide area network (LoRaWAN) infrastructure. Founded in 2006 and based in Portsmouth, New Hampshire, the company offers a range of services including network planning and management, consulting, and developer portal services. Senet's cloud-based managed network services facilitate long-distance sensor connectivity, enabling businesses to efficiently monitor and manage distributed assets. Its offerings support various applications such as residential fuel oil and propane tank automation, water and gas metering, and commercial lubrication distribution. By providing cost-effective solutions, Senet empowers enterprises to leverage data-driven insights in the rapidly evolving Machine-to-Machine (M2M) IoT landscape.

Carmell Cosmetics

Series A in 2014
Carmell was founded in 2007 to commercialize technology developed jointly at Carnegie Mellon University and Allegheny General Hospital. The proprietary technology enables the manufacture of biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. These plastics are sterile, off-the-shelf, easy to handle, shape and suture, have controlled degradation rates, contain known levels of bioactivity, and exhibit mechanical properties designed to match the repaired tissue. Carmell's plastics can be simply viewed as plastic forms of ultra-concentrated blood clots; they therefore represent the ideal biomaterials, using the body's own growth and regenerative factors to naturally promote tissue healing. The Company is focused on the sports medicine market, with products designed to accelerate healing and produce better clinical outcomes in treating injuries to connective tissue (e.g., tendons, ligaments and cartilage).

Alcyone Lifesciences

Series B in 2014
Alcyone Lifesciences, Inc. is a biotechnology company dedicated to developing innovative treatment options for oncology and chronic neurological conditions. Founded in 2010 and headquartered in Lowell, Massachusetts, the company specializes in advanced delivery systems, notably the Alcyone MEMS Cannula system, which allows neurosurgeons to accurately target regions within the brain and deliver therapeutic agents with real-time MRI guidance. This technology addresses significant challenges in treating various neurologic disorders, including brain tumors, hydrocephalus, epilepsy, and neurodegenerative diseases, particularly by overcoming the limitations posed by the blood-brain barrier. Alcyone Lifesciences aims to enhance molecular therapy precision and control, thereby transforming treatment approaches for rare and orphan neurological disorders.

Terascala

Venture Round in 2013
Terascala, based in Boston, specializes in the development of advanced storage appliances designed to enhance data processing capabilities for organizations utilizing simulation, analysis, and modeling tools. These appliances significantly reduce the time required to derive insights, thereby facilitating faster innovation and product development. Terascala's storage solutions are exclusively available through strategic partnerships with prominent companies such as Dell, EMC, and NetApp. By leveraging these industry-leading storage platforms, Terascala ensures high throughput performance and robust long-term data protection for its clients.

EnerTrac

Series A in 2013
EnerTrac, Inc. is a company based in Portsmouth, New Hampshire, founded in 2009, that specializes in fuel delivery and monitoring solutions for fuel dealers. As a subsidiary of WESROC Monitoring Solutions, EnerTrac offers an innovative tank monitoring system that automates the measurement and monitoring of fuel oil and propane tanks. This system includes various components such as tank monitors, cloud software, mobile applications, and float arm assemblies, enabling fuel dealers to accurately determine when a customer's tank requires refilling. By utilizing a low-frequency, cost-effective communication network, EnerTrac provides actionable data that enhances the efficiency of delivery schedules, ultimately saving fuel and reducing emissions. The technology also supports machine-to-machine communication and has the potential to extend its monitoring capabilities to other systems, including thermostats and HVAC units.

Draker

Venture Round in 2012
Draker is a company that specializes in providing monitoring, management, and control solutions for commercial and utility solar energy systems. With over a decade of experience, Draker offers a comprehensive range of products and services designed to enhance the efficiency and profitability of photovoltaic (PV) assets for developers, owners, and operators. Their solutions include project-based services, field instrumentation, data collection and management systems, and advanced web applications featuring analytical tools. Additionally, Draker offers public information displays to ensure comprehensive oversight of solar energy performance. Through these capabilities, Draker enables enterprises to maximize the effectiveness of their green power technologies and effectively manage their solar energy portfolios.

Vets First Choice

Venture Round in 2012
Vets First Choice provides veterinary practices with an online pharmacy and home delivery services. It partners with veterinarians to create insight into gaps in patient care and offer professionalized pro-active prescription management to drive client engagement and improve compliance. The company was founded by Ben Shaw in 2010 and is based in Portland, Maine.

Courtagen Life Sciences

Series B in 2011
Courtagen Life Sciences, Inc. is a biotechnology company based in Woburn, Massachusetts, specializing in genetic testing services. The company provides a range of clinical genetic tests focused on neurological conditions, including developmental delay, intellectual disability, autism spectrum disorders, epilepsy, and mitochondrial disorders. Its offerings include comprehensive analyses such as epiSEEK Comprehensive and epiSEEK Focus, which assess genes associated with neurological function and seizure disorders, respectively. Additionally, Courtagen offers tests for drug metabolism related to epilepsy, as well as panels for neurodevelopmental and lysosomal storage disorders. The company also provides next generation sequencing services to support research in target discovery, clinical development, and companion diagnostics. Founded in 2003, Courtagen Life Sciences aims to empower physicians, families, and children affected by neurological disorders through advanced genetic insights.

Draker

Venture Round in 2011
Draker is a company that specializes in providing monitoring, management, and control solutions for commercial and utility solar energy systems. With over a decade of experience, Draker offers a comprehensive range of products and services designed to enhance the efficiency and profitability of photovoltaic (PV) assets for developers, owners, and operators. Their solutions include project-based services, field instrumentation, data collection and management systems, and advanced web applications featuring analytical tools. Additionally, Draker offers public information displays to ensure comprehensive oversight of solar energy performance. Through these capabilities, Draker enables enterprises to maximize the effectiveness of their green power technologies and effectively manage their solar energy portfolios.

Carmell Cosmetics

Series A in 2011
Carmell was founded in 2007 to commercialize technology developed jointly at Carnegie Mellon University and Allegheny General Hospital. The proprietary technology enables the manufacture of biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. These plastics are sterile, off-the-shelf, easy to handle, shape and suture, have controlled degradation rates, contain known levels of bioactivity, and exhibit mechanical properties designed to match the repaired tissue. Carmell's plastics can be simply viewed as plastic forms of ultra-concentrated blood clots; they therefore represent the ideal biomaterials, using the body's own growth and regenerative factors to naturally promote tissue healing. The Company is focused on the sports medicine market, with products designed to accelerate healing and produce better clinical outcomes in treating injuries to connective tissue (e.g., tendons, ligaments and cartilage).

Micronotes

Venture Round in 2010
Micronotes, Inc. is a digital marketing company based in Boston, Massachusetts, specializing in SaaS solutions for financial institutions. Founded in 2008, it leverages artificial intelligence and machine learning to enhance customer engagement and improve cross-selling of financial products. The company's flagship product, Cross-Sell, is a digital interview platform that utilizes customer data to generate personalized financial service offers. Additionally, Micronotes offers tools such as Mobile-SMS, which automates the referral process through customer interviews conducted via mobile phones, and a Net Promoter Score Measurement tool to assess customer loyalty. By applying these technologies, Micronotes enables financial institutions to better understand customer needs, drive sales opportunities, and foster stronger relationships with both existing and potential clients.

Eggrock Partners

Venture Round in 2009
Eggrock Partners, Inc. operates as a consulting and systems integration company that focuses on delivering e-business solutions to emerging enterprises. The company is based in Concord, Massachusetts. As of March 31, 2000, Eggrock Partners, L.L.C. is a subsidiary of Breakaway Solutions, Inc.

FetchDog

Series A in 2009
FetchDog is an online destination for dog owners to shop, learn and socialize. They offer passionate dog people a place to find quality dog supplies and credible advice on their dog’s health and wellness. Their products include pets, dog beds, dog homes, dog collars, leashes and harnesses, dog apparel, dog toys, treats, bowls, dog travel, and more.

Draker

Series A in 2008
Draker is a company that specializes in providing monitoring, management, and control solutions for commercial and utility solar energy systems. With over a decade of experience, Draker offers a comprehensive range of products and services designed to enhance the efficiency and profitability of photovoltaic (PV) assets for developers, owners, and operators. Their solutions include project-based services, field instrumentation, data collection and management systems, and advanced web applications featuring analytical tools. Additionally, Draker offers public information displays to ensure comprehensive oversight of solar energy performance. Through these capabilities, Draker enables enterprises to maximize the effectiveness of their green power technologies and effectively manage their solar energy portfolios.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.